Organoids derived from stem cells are giving researchers new ways to study how human tissues form and how diseases emerge. By introducing vascular structures, scientists can mimic complex organ development processes. Meanwhile, brain organoids created from patient-derived cells are providing deeper insights into the cellular and molecular changes linked to neurological disorders.
In this webinar, Oscar Abilez and Thomas Durcan will discuss their work on building vascularized cardiac and hepatic organoids and on developing brain organoids for modeling Parkinson’s disease.
Topics to be covered:
- Creating vascularized organoids to mimic early stages of heart and liver development
- Generating brain organoids from patient-derived stem cells to study Parkinson’s disease
Speakers
Oscar Abilez, MD, PhD
Senior Scientist
Stanford University
Thomas Durcan, PhD
Director
The Neuro’s Early Drug Discovery Unit
McGill University
Supported by
Related Industries
-
Pharmaceutical
Under continual pressure to increase profitability, maintain government compliance, and meet emerging market opportunities, the pharmaceutical manufacturing industry faces unique challenges that require unique solutions. As one of the world’s leading industrial automation suppliers, Yokogawa is poised and prepared to deliver those solutions, creating individualized lean manufacturing techniques that deliver consistent, measurable results.
Related Products & Solutions
-
High-Content Analysis Systems
Utilizing powerful software, high-content analysis (HCA) systems address a wide range of research applications from basic science to complex compound screening.
-
Life Science
Yokogawa’s sensitivity and precision solutions enable rapid and accurate measurements, empowering groundbreaking research, accelerating drug discovery, and optimizing bio-production at scale.